IRLAB Therapeutics AB (publ) (STO:IRLAB.A)

IRLAB Therapeutics AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 14, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	161	558	389	1,987	2,277	2,173
Market Cap Growth	-71.09%	43.33%	-80.42%	-12.75%	4.76%	37.75%
Enterprise Value	81	527	271	1,699	1,853	2,006
Last Close Price	1.90	10.15	7.08	36.16	41.54	39.65
PE Ratio	-	-	-	-	43.97	-
PS Ratio	1.88	5.89	68.51	32.49	10.96	7244.78
PB Ratio	2.97	17.09	3.36	6.83	5.70	6.25
P/TBV Ratio	21.94	-	5.65	8.14	6.38	8.16
P/FCF Ratio	-	-	-	-	17.80	-
P/OCF Ratio	-	-	-	-	17.70	-
EV/Sales Ratio	0.95	5.57	47.82	27.79	8.92	6687.21
EV/EBITDA Ratio	-	-	-	-	34.92	-
EV/EBIT Ratio	-	-	-	-	35.25	-
EV/FCF Ratio	-	-	-	-	14.49	-
Debt / Equity Ratio	0.55	1.85	0.24	0.01	0.02	0.01
Debt / EBITDA Ratio	-	-	-	-	0.12	-
Debt / FCF Ratio	-	-	-	-	0.05	-
Asset Turnover	0.52	0.60	0.02	0.15	0.49	0.00
Quick Ratio	1.30	0.77	3.28	8.19	5.95	13.47
Current Ratio	1.30	0.80	3.37	8.31	6.07	13.56
Return on Equity (ROE)	-199.29%	-112.03%	-87.48%	-32.86%	13.86%	-34.61%
Return on Assets (ROA)	-27.35%	-29.11%	-44.96%	-17.59%	7.80%	-19.80%
Return on Invested Capital (ROIC)	-49.63%	-38.59%	-51.38%	-19.98%	8.68%	-21.31%
Return on Capital Employed (ROCE)	-89.90%	-201.70%	-128.30%	-38.50%	13.00%	-26.20%
Earnings Yield	-57.01%	-14.91%	-45.72%	-5.71%	2.27%	-4.22%
FCF Yield	-	-11.80%	-42.45%	-7.32%	5.62%	-4.12%
Buyback Yield / Dilution	-13.14%	-	-0.07%	-0.16%	-8.54%	-17.45%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.